Regulatory tracker: AstraZeneca nabs key Imfinzi lung cancer approval in Europe
In this tracker, Fierce Pharma is recording the regulatory progress of in-market products, including expansions into key geographies and new indications. Some of these updates may not meet the bar for standalone stories, but we think they are still worth mentioning.
